The global tissue engineered skin substitutes market is expected to grow from USD 2.01 billion in 2019 to USD 7.3 billion by 2027, at a CAGR of 17.5% during the forecast period 2020-2027.
Tissue engineering is a method for maintaining, restoring, or improving damaged organs and tissues. It uses a mixture of biologically active molecules, scaffolds, and cells for developing functional tissues. The tissue engineered skin substitutes are alternatives for traditional tissue generation and wound healing techniques. They help in fulfilling the deficiency in skin graft supplies. They help in the protection of damaged skin parts from loss of fluid and contamination, along with accelerating the process of healing the wound.
The increasing use of tissue engineered skin substitutes in the treatment of diabetic foot ulcers, and pressure ulcers is expected to drive market growth. The rising prevalence of chronic wounds and excess skin loss will further boost the market growth. The increasing investments in the development of complex skin substitutes and dermo epidermal substitutes is anticipated to fuel market growth. The rising demand for breast reconstruction is also expected to contribute to market growth.
This study delivers a comprehensive analysis of type, application, end-user, and regions. On the basis of type, the market can be divided into synthetic, biosynthetic, and biological skin substitutes. The biological skin substitutes can be classified into allograft and xenograft skin substitutes. The allograft skin substitutes can be further classified into cellular allograft and acellular allograft. Biological skin substitutes are expected to dominate the market during the forecast period. The extensive use of biological materials in tissue regeneration is gaining momentum. On the basis of application, the market can be divided into burn injury, diabetic foot ulcers, chronic wounds, and others. Diabetic foot ulcer is expected to dominate the market and show significant growth rate during the forecast period. The increase in geriatric population is giving a rise to incidences of ulcers due to their weak immunity and reduced blood flow. On the basis of end-users, the market can be divided into hospitals and other healthcare facilities.
The market for tissue engineered skin substitutes has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. North America is expected to dominate the market during the forecast period. The rapid changing lifestyles of people has led to increasing prevalence of cardiovascular diseases in the region. Asia-Pacific region is expected to witness the highest growth rate during the forecast period. The high geriatric population in countries like Japan and South Korea is expected to fuel the market growth.
Some of the leading players include Organogenesis, Inc., Amarantus BioScience Holdings, Acelity L.P., Inc., BSN Medical, Smith & Nephew plc, Molnlycke Health Care, Medtronic, Integra LifeSciences Corporation, Tissue Regenix Ltd., and Stratatech Corporation.
Global Tissue Engineered Skin Substitutes Market Analysis And Forecast, By Type
Global Tissue Engineered Skin Substitutes Market Analysis And Forecast, By Application
Global Tissue Engineered Skin Substitutes Market Analysis And Forecast, By End-Users
Global Tissue Engineered Skin Substitutes Market Analysis And Forecast, By Regional Analysis
Report Description:
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Application
4.3.2. Market Attractiveness Analysis By End User
4.3.3. Market Attractiveness Analysis By Type
4.3.4. Market Attractiveness Analysis By Region
4.4. Application Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges
6. Global Tissue Engineered Skin Substitutes Market Analysis and Forecast, By Application
6.1. Segment Overview
6.2. Burn Injury
6.3. Diabetic Foot Ulcers
6.4. Chronic Wounds
6.5. Others
7. Global Tissue Engineered Skin Substitutes Market Analysis and Forecast, By End User
7.1. Segment Overview
7.2. Hospitals
7.3. Other Healthcare Facilities
8. Global Tissue Engineered Skin Substitutes Market Analysis and Forecast, By Type
8.1. Segment Overview
8.2. Synthetic
8.3. Biosynthetic
8.4. Biological
8.4.1. Allograft
8.4.1.1. Cellular Allograft
8.4.1.2. Acellular Allograft
8.4.2. Xenograft
9. Global Tissue Engineered Skin Substitutes Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Tissue Engineered Skin Substitutes Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in Global Tissue Engineered Skin Substitutes Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. Organogenesis, Inc
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Amarantus BioScience Holdings
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. Acelity L.P
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. BSN Medical
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Smith & Nephew plc
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. Molnlycke Health Care
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Medtronic
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. Integra LifeSciences Corporation
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Tissue Regenix Ltd
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Stratatech Corporation
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
List of Table
1. Global Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
2. Global Burn Injury Tissue Engineered Skin Substitutes Market, By Region, 2017–2027 (USD Billion)
3. Global Diabetic Foot Ulcers Tissue Engineered Skin Substitutes Market, By Region, 2017–2027 (USD Billion)
4. Global Chronic Wounds Tissue Engineered Skin Substitutes Market, By Region, 2017–2027 (USD Billion)
5. Global Others Tissue Engineered Skin Substitutes Market, By Region, 2017–2027 (USD Billion)
6. Global Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
7. Global Synthetic, Tissue Engineered Skin Substitutes Market, By Region, 2017–2027 (USD Billion)
8. Global Biosynthetic, Tissue Engineered Skin Substitutes Market, By Region, 2017–2027 (USD Billion)
9. Global Biological, Tissue Engineered Skin Substitutes Market, By Region, 2017–2027 (USD Billion)
10. Global Allograft, Biological Market, By Region, 2017–2027 (USD Billion)
11. Global Cellular Allograft, Allograft Market, By Region, 2017–2027 (USD Billion)
12. Global Acellular Allograft, Allograft Market, By Region, 2017–2027 (USD Billion)
13. Global Xenograft, Biological Market, By Region, 2017–2027 (USD Billion)
14. Global Tissue Engineered Skin Substitutes Market, By End User , 2017–2027 (USD Billion)
15. Global Hospitals, Tissue Engineered Skin Substitutes Market, By Region, 2017–2027 (USD Billion)
16. Global Other Healthcare Facilities, Tissue Engineered Skin Substitutes Market, By Region, 2017–2027 (USD Billion)
17. Global Tissue Engineered Skin Substitutes Market, By Region, 2017–2027 (USD Billion)
18. Global Tissue Engineered Skin Substitutes Market, By North America, 2017–2027 (USD Billion)
19. North America Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
20. North America Tissue Engineered Skin Substitutes Market, By End User , 2017–2027 (USD Billion)
21. North America Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
22. U.S. Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
23. U.S. Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
24. U.S. Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
25. Canada Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
26. Canada Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
27. Canada Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
28. Mexico Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
29. Mexico Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
30. Mexico Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
31. Europe Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
32. Europe Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
33. Europe Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
34. Germany Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
35. Germany Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
36. Germany Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
37. France Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
38. France Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
39. France Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
40. U.K Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
41. U.K Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
42. U.K Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
43. Italy Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
44. Italy Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
45. Italy Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
46. Spain Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
47. Spain Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
48. Spain Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
49. Asia Pacific Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
50. Asia Pacific Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
51. Asia Pacific Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
52. Japan Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
53. Japan Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
54. Japan Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
55. China Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
56. China Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
57. China Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
58. India Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
59. India Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
60. India Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
61. South America Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
62. South America Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
63. South America Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
64. Brazil Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
65. Brazil Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
66. Brazil Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
67. Middle East and Africa Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
68. Middle East and Africa Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
69. Middle East and Africa Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
70. UAE Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
71. UAE Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
72. UAE Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
73. South Africa Tissue Engineered Skin Substitutes Market, By Application, 2017–2027 (USD Billion)
74. South Africa Tissue Engineered Skin Substitutes Market, By End User, 2017–2027 (USD Billion)
75. South Africa Tissue Engineered Skin Substitutes Market, By Type , 2017–2027 (USD Billion)
List of Figures
1. Global Tissue Engineered Skin Substitutes Market Segmentation
2. Tissue Engineered Skin Substitutes Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Tissue Engineered Skin Substitutes Market Attractiveness Analysis By Application
9. Global Tissue Engineered Skin Substitutes Market Attractiveness Analysis By Type
10. Global Tissue Engineered Skin Substitutes Market Attractiveness Analysis By End User
11. Global Tissue Engineered Skin Substitutes Market Attractiveness Analysis By Region
12. Global Tissue Engineered Skin Substitutes Market: Dynamics
13. Global Tissue Engineered Skin Substitutes Market Share by Application (2020 & 2027)
14. Global Tissue Engineered Skin Substitutes Market Share by Type (2020 & 2027)
15. Global Tissue Engineered Skin Substitutes Market Share by End User (2020 & 2027)
16. Global Tissue Engineered Skin Substitutes Market Share by Regions (2020 & 2027)
17. Global Tissue Engineered Skin Substitutes Market Share by Company (2019)
Market research is a method of gathering, assessing and deducing data & information about a particular market. Market research is very crucial in these days. The techniques analyze about how a product/service can be offered to the market to its end-customers, observe the impact of that product/service based on the past customer experiences, and cater their needs and demands. Owing to the successful business ventures, accurate, relevant and thorough information is the base for all the organizations because market research report/study offers specific market related data & information about the industry growth prospects, perspective of the existing customers, and the overall market scenario prevailed in past, ongoing present and developing future. It allows the stakeholders and investors to determine the probability of a business before committing substantial resources to the venture. Market research helps in solving the marketing issues challenges that a business will most likely face.
Market research is valuable because of the following reasons:
Our research report features both the aspects; qualitative and quantitative. Qualitative part provides insights about the market driving forces, potential opportunities, customer’s demands and requirement which in turn help the companies to come up with new strategies in order to survive in the long run competition. The quantitative segment offers the most credible information related to the industry. Based on the data gathering, we use to derive the market size and estimate their future growth prospects on the basis of global, region and country.
Our market research process involves with the four specific stages.
Data Collection: This stage of the market research process involves with the gathering and collecting of the market/industry related data from the sources. There are basically two types of research methods:
Data Synthesis: This stage includes the evaluation and assessment of all the data acquired from the primary and secondary research. It likewise includes in evaluating the information for any disparity watched while information gathering identified with the market. The data & information is gathered with consideration to the heterogeneity of sources. Scientific and statistical methods are implemented for synthesizing dissimilar information sets and provide the relevant data which is fundamental for formulating strategies. Our organization has broad involvement with information amalgamation where the information goes through different stages:
Market Formulation & Deduction: The last stage includes assigning the data & information in a suitable way in order to derive market size. Analyst reviews and domain based opinions based on holistic approach of market estimation combined with industry investigation additionally features a crucial role in this stage.
This stage includes with the finalization of the market size and numbers that we have gathered from primary and secondary research. With the data & information addition, we ensure that there is no gap in the market information. Market trend analysis is finished by our analysts by utilizing data extrapolation procedures, which give the most ideal figures to the market.
Data Validation: Validation is the most crucial step in the process. Validation & re-validation through scientifically designed technique and process that helps us finalize data-points to be used for final calculations. This stage also involves with the data triangulation process. Data triangulation generally implicates the cross validation and matching the data which has been collected from primary and secondary research methods.
Free Customization
Countries can be added on demand
Free yearly update on purchase of Multi/Corporate User License
Companies served till date
We serve our customers 24x7 for 365 days through calls, emails and live chat options.
Huge database of exceptional market reports bringing market intelligence to your fingertips.
SSL enabled, we offer you various secured payment options for risk free purchase.